Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations

  • Authors:
    • Ewa Wybieralska
    • Katarzyna Szpak
    • Andrzej Górecki
    • Piotr Bonarek
    • Katarzyna Miękus
    • Justyna Drukała
    • Marcin Majka
    • Krzysztof Reiss
    • Zbigniew Madeja
    • Jarosław Czyż
  • View Affiliations

  • Published online on: May 26, 2011     https://doi.org/10.3892/or.2011.1321
  • Pages: 447-453
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the present study, we investigated the effects of fenofibrate on the invasive potential of DU-145 human prostate cancer cells in the context of gap junctional intercellular coupling and the formation of reactive oxygen species. Time-lapse analyses of cell motility, accompanied by tests of cell viability, membrane microviscosity, reactive oxygen species accumulation and the function of gap junctional protein connexin 43 were performed in monolayer cultures of DU-145 cells following fenofibrate administration. Fenofibrate inhibited the motility of DU-145 cells and attenuated gap junctional intercellular coupling in a manner independent of its effects on cell viability, PPARα activation and cell membrane micro­viscosity. Instead, N-acetyl-L-cysteine, a scavenger of reactive oxygen species, restored cell motility and gap junctional coupling in fenofibrate-treated DU-145 cell populations. These data indicate that two parameters crucial for cancer cell metastatic potential, i.e. cell motility and gap junctional coupling, are inhibited by fenofibrate. Thus, fenofibrate affects prostate cancer cell invasion via an orchestrated action on versatile cancer cell properties determining this process. A novel mechanism of anti-invasive activity of fenofibrate, which depends on its interference with cell motility and the function of gap junctions regulated by reactive oxygen species, is suggested.

Related Articles

Journal Cover

August 2011
Volume 26 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wybieralska E, Szpak K, Górecki A, Bonarek P, Miękus K, Drukała J, Majka M, Reiss K, Madeja Z, Czyż J, Czyż J, et al: Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations. Oncol Rep 26: 447-453, 2011
APA
Wybieralska, E., Szpak, K., Górecki, A., Bonarek, P., Miękus, K., Drukała, J. ... Czyż, J. (2011). Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations. Oncology Reports, 26, 447-453. https://doi.org/10.3892/or.2011.1321
MLA
Wybieralska, E., Szpak, K., Górecki, A., Bonarek, P., Miękus, K., Drukała, J., Majka, M., Reiss, K., Madeja, Z., Czyż, J."Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations". Oncology Reports 26.2 (2011): 447-453.
Chicago
Wybieralska, E., Szpak, K., Górecki, A., Bonarek, P., Miękus, K., Drukała, J., Majka, M., Reiss, K., Madeja, Z., Czyż, J."Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations". Oncology Reports 26, no. 2 (2011): 447-453. https://doi.org/10.3892/or.2011.1321